Document Detail


Impact of acute biochemical castration on insulin sensitivity in healthy adult men.
MedLine Citation:
PMID:  20408755     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Evidence supports an inverse relationship between serum testosterone (T) and insulin resistance in men. However, data with respect to causality are limited. The aim of this study was to explore the impact of acute biochemical castration on insulin sensitivity in healthy adult men. METHODS: Ten healthy, adult males (mean age 41.0 +/- 3.9 yr) were studied. Subjects were studied at baseline and after 2 and 4 weeks of biochemical castration. Outpatient hospital research setting. Body composition (dual-energy x-ray absorptiometry), energy expenditure (indirect calorimetry), abdominal and visceral adiposity (MRI), skeletal muscle intramyocellular lipid content ([IMCL] (1)H-MR spectroscopy), and insulin sensitivity (hyperinsulinemic-euglycemic clamp) were assessed before and after 2 and 4 weeks of biochemical castration induced by a GnRH antagonist (acyline 300 mug/kg subcutaneous every 10-14 days). Serum T, insulin and glucose levels, body composition, abdominal visceral fat, IMCL, and glucose disposal rate (M) were measured. RESULTS AND CONCLUSION: Acyline administration suppressed serum T to frankly hypogonadal levels in all subjects for the duration of the study (P <0.009). No significant changes in body composition, energy expenditure, or M were observed at either 2 or 4 weeks of castration. Acyline is an effective GnRH antagonist inducing acute castration in all subjects. ii) Four weeks of biochemical castration has no impact on insulin sensitivity in healthy men likely due to unchanged body composition variables. iii) Insulin resistance associated with chronic low T levels may be largely driven by decreased fat free mass, increased percent body fat, and/or other metabolic regulatory factors.
Authors:
Atoosa Rabiee; Andrew A Dwyer; Lisa M Caronia; Frances J Hayes; Maria A Yialamas; Dana K Andersen; Bijoy Thomas; Martin Torriani; Dariush Elahi
Related Documents :
17965035 - Effects of tai chi on glucose homeostasis and insulin sensitivity in older adults with ...
15886255 - Lower-body adiposity and metabolic protection in postmenopausal women.
6118065 - Investigation of kinetics of integrated metabolic response to adrenergic blockade in co...
16505525 - Abdominal adiposity is a stronger predictor of insulin resistance than fitness among 50...
16895955 - Increased subcutaneous and epicardial adipose tissue production of proinflammatory cyto...
21318975 - Intensive insulin therapy for japanese patients with type 2 diabetes mellitus - results...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Endocrine research     Volume:  35     ISSN:  1532-4206     ISO Abbreviation:  Endocr. Res.     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-04-22     Completed Date:  2010-07-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8408548     Medline TA:  Endocr Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  71-84     Citation Subset:  IM    
Affiliation:
Department of Surgery and Department of Medicine, Johns Hopkins Medical School, Baltimore, Maryland, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Blood Glucose / metabolism
Body Composition / physiology
Estradiol / blood
Follicle Stimulating Hormone / blood
Gonadotropin-Releasing Hormone / antagonists & inhibitors
Humans
Insulin / blood*
Insulin Resistance / physiology*
Intra-Abdominal Fat / metabolism
Luteinizing Hormone / blood
Male
Middle Aged
Muscle, Skeletal / metabolism
Oligopeptides / administration & dosage
Orchiectomy*
Sex Hormone-Binding Globulin / metabolism
Subcutaneous Fat / metabolism
Testosterone / blood*
Young Adult
Chemical
Reg. No./Substance:
0/Blood Glucose; 0/Oligopeptides; 0/Sex Hormone-Binding Globulin; 11061-68-0/Insulin; 170157-13-8/acyline; 33515-09-2/Gonadotropin-Releasing Hormone; 50-28-2/Estradiol; 58-22-0/Testosterone; 9002-67-9/Luteinizing Hormone; 9002-68-0/Follicle Stimulating Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Production of a type 2 maternal diabetes rodent model using the combination of high-fat diet and mod...
Next Document:  Insulin resistance before and after parathyroidectomy in patients with primary hyperparathyroidism--...